Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ditropan 2.5mg tablets
0704020J0BCAAAA
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3,389 |
|
Ditropan 5mg tablets
0704020J0BCABAC
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,079 |
|
Ditropan 2.5mg/5ml elixir
0704020J0BCACAZ
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ditropan XL 10mg tablets
0704020J0BCAFAT
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ditropan XL 5mg tablets
0704020J0BCAGAS
|
Ditropan (Urinary Incontinence) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.